Asian EMs going strong amid trade war fears
Emerging markets (EMs) have had a surprisingly strong start to the year considering that the past month has been dominated by talks of a potential trade war, with the EM Equities sector recording average returns of 3.22 per cent for the March quarter according to FE Analytics.
The top performing funds were the GMO Emerging Markets fund, returning 6.55 per cent for the quarter, the Colonial First State RAFI Emerging Markets fund with 5.63 per cent and the Robeco Emerging Conservative Equity fund with 5.45 per cent.
The GMO fund was also the strongest performer for the year to 31 March, 2018, delivering impressive returns of 20.57 per cent.
The only fund to record negative returns for the quarter was the BT Wholesale Global Emerging Markets Opportunities fund, with –0.85 per cent.
Global market strategist at JP Morgan Asset Management, Kerry Craig, speaking before the launch of JP Morgan’s latest Guide to the Markets – Australia yesterday, said that these generally strong performances looked set to continue.
“We believe that emerging markets are approaching only the middle of their cycle, especially with the striking breadth of earnings growth across sectors. Moreover, EM multiples are still just approaching their long-term averages, which suggests ample opportunity for future gains.
“In particular, EM valuations remain attractive relative to developed markets including the US, where valuations are above their long-term average,” he found in the Guide.
Craig said that the growth differential with developed market equities had widened so we were seeing EM stocks generate greater alpha. The Guide found that the wider emerging-developed markets differential should continue to boost foreign direct investments and portfolio inflows into EM equities.
Interestingly, data from FE Analytics revealed that both the GMO and Robeco funds were heavily exposed to EMs in the Asia Pacific specifically. Almost three quarters of Robeco’s investments, for example, were invested in Asian EMs, with Chinese, Taiwanese, Malaysian and South Korean equities having the strongest presence. GMO had 28.6 per cent of its assets in the region too.
Reflecting this, Kerry said that EMs had performed surprisingly well in the last quarter despite talks of a trade war between the US and China.
“EM equities remain underpinned by the continuing improvement in corporate earnings and fundamentals brought about by a strong Chinese economy as well as the ongoing, synchronised global trade recovery,” JP Morgan said.
In fact, EMs in Asia could be a pertinent market for investors in search of long-term growth to look to in portfolio construction.
“Importantly, EM is still a very under-owned asset class, and we remain convinced by emerging markets’ long-term structural prospects, especially in emerging Asia,” Craig said.
He was also reassured that the qualities that have characterised emerging markets in Asia should not be overly impacted by risks of a trade war.
AUTHOR
Hannah Wootton
Recommended for you
Clime Investment Management has faced shareholder backlash around “unsatisfactory” financial results and is enacting cost reductions to return the business to profitability by Q1 2025.
Amid a growing appetite for alternatives, investment executives have shared questions advisers should consider when selecting a private markets product compared to their listed counterparts.
Chief executive Maria Lykouras is set to exit JBWere as the bank confirms it is “evolving” its operations for high-net-worth clients.
Bennelong Funds Management chief executive John Burke has told Money Management that the firm is seeking to invest in boutiques in two specific asset classes as it identifies gaps in its product range.
